# Effects of Metformin on Hepatic FFA Metabolism

> **NCT01729156** · PHASE4 · COMPLETED · sponsor: **Lars Christian Gormsen** · enrollment: 36 (actual)

## Conditions studied

- Type 2 Diabetes
- Dyslipidemia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01729156
- **Lead sponsor:** Lars Christian Gormsen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2017-05-05
- **Final completion:** 2017-05-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01729156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01729156, "Effects of Metformin on Hepatic FFA Metabolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01729156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*